| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-05 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |